News
-
-
-
-
-
REGULATED PRESS RELEASE
Availability of preparatory documents for the 2024 Combined General Meeting
Edenred announces the availability of preparatory documents for the 2024 Combined General Meeting on May 7, 2024. Shareholders can participate remotely and access related information on the Company's website -
REGULATED PRESS RELEASE
Mise à disposition des documents préparatoires à l'Assemblée générale mixte 2024
Mise à disposition des documents préparatoires à l’Assemblée générale mixte 2024 d'Edenred pour les actionnaires avec modalités de participation et diffusion en direct et différé en français et anglais -
PRESS RELEASE
Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
Marinomed Biotech AG announces 2023 financial year results, highlighting progress with Marinosolv and Carragelose assets. Focus on achieving operating profitability and commercialization -
PRESS RELEASE
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
PharmaSGP surpasses €100 million revenues in 2023, plans growth in 2024. Achieved 17.8% revenue increase and 20.8% rise in adjusted EBITDA. Forecasts €107-112 million revenues and €35-38 million EBITDA for 2024 -
-